A Critical Regulatory Deadline Is Approaching

The European Union’s EUDAMED database is moving toward mandatory use under the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). While many manufacturers are aware of the system, fewer understand the operational work required to successfully register devices before the following upcoming regulatory deadlines:

• By May 28, 2026, all new MDR or IVDR devices must be fully registered in EUDAMED before being placed on the market.
• By November 27, 2026, devices already placed on the market before May 28, 2026, including “legacy” devices (those already marketed under certificates during the transition period) must also be registered in EUDAMED.

An important point to note—many manufacturers mistakenly believe the process is automatic, or that their Notified Body (NB) or Authorized Representative (EC REP) will handle it. In practice, the manufacturer is the sole legal entity responsible for ensuring the integrity and submission of its UDI data.

For most organizations, the biggest challenge will be the complexity of preparing device data, documentation, and internal processes required for successful registration.

Why EUDAMED Registration Is More Complex Than Many Expect

At first glance, EUDAMED appears to simply be a centralized database for listing medical devices. In practice, however, it is a highly structured system with discrete roles and responsibilities requiring coordinated data across multiple regulatory modules.

The following data are required:

• Actor registration and Single Registration Numbers (SRN)
• Unique Device Identification (UDI) data
• Device master records
• Notified Body certificate information
• Regulatory documentation aligned with MDR or IVDR

Below lists who is responsible and their role in the registration process:

• The Notified Body (NB): Exclusively uploads information regarding Certificates.
• The Authorized Representative (EC REP): Validates the Actor Registration request (SRN). However, the EC REP does not have the functional role of validating UDI uploads.
• The Manufacturer: Is the final party responsible for uploading device data (UDI-DI).

Each of the data elements listed above must be accurate, properly structured, and organized before submission. Ensuring full consistency between device data and Notified Body certificates is essential to prevent potential administrative issues or unnecessary delays in commercialization.

Data Preparation Is Often the Biggest Challenge

One of the most significant hurdles manufacturers face is preparing structured device data that aligns with EUDAMED requirements.

Many companies maintain device information across multiple internal systems—quality systems, regulatory databases, product lifecycle tools, and spreadsheets. Consolidating this information into a consistent format that meets EUDAMED standards can require substantial internal coordination.

The Technical Challenge: Manual vs. XML Bulk Upload

Organizations with large device portfolios may need to prepare hundreds or even thousands of device records, each requiring validation before submission. In these cases, manual data entry is an error-prone, high-risk strategy and strongly discouraged.

XML bulk uploads are another option for large device portfolios. However, mass registration requires generating XML files that strictly comply with EUDAMED’s XSD schemas and a single formatting error can reject an entire bulk upload.

Data integrity is a significant challenge for organizations with large device portfolios. Consolidating over 120 fields per entry (from risk class to critical components) requires a level of data cleansing that most internal IT departments are not prepared to execute alone.

Common EUDAMED Preparation Mistakes

Companies that delay preparation or underestimate the complexity of EUDAMED registration often encounter similar issues.

Common challenges include:

• Missing or incomplete UDI data
• Incorrect device classifications
• Misalignment between device records and Notified Body certificates
• Inconsistent device descriptions across systems
• Lack of internal resources dedicated to the registration process

Addressing these issues late in the process can create significant delays, particularly as regulatory teams face competing priorities.

Why Starting Early Matters

With the May 2026 deadline approaching for new devices, manufacturers introducing products into the EU market will need to ensure registrations are completed before commercialization.

For organizations with existing device portfolios, the November 2026 deadline may require a substantial effort to review and register all devices currently on the market.

Companies that begin preparation early will have more time to identify data gaps, validate documentation, and ensure submissions are completed without last-minute pressure.

Preparing Your Organization for EUDAMED

Successful EUDAMED registration requires a structured approach that combines regulatory expertise, organized device data, and clear internal processes.

Manufacturers should consider taking the following steps:

• Conduct an internal readiness assessment
• Confirm actor registration and SRN status
• Review UDI preparation for all applicable devices
• Align device records with Notified Body certificates
• Establish a timeline for portfolio submission

Early preparation can significantly reduce risk and ensure continued access to the EU market.

A Note on  Swissdamed and the CH REP

Medical device companies that operate in Switzerland need to be aware that registration with Swissdamed is required and separate from EUDAMED registration. This requires a parallel workflow (as EUDAMED described above) and the mandatory designation of a Swiss Authorized Representative (CH REP). Since CMC Medical Devices has strategic offices in Switzerland, we manage this double compliance in a synchronized manner.

Registrar Corp and CMC: Your Trusted Regulatory Partner

With critical EUDAMED and Swissdamed deadlines fast approaching, it is critical to act now and ensure your regulatory submissions are fully prepared and compliant. Registrar Corp and CMC Medical Devices partner with medical device manufacturers worldwide to simplify the daunting regulatory landscape. Our team delivers hands-on support—from organizing and structuring device data to validating complex regulatory documentation and managing every stage of your EUDAMED and Swissdamed registration.

By leveraging our proven expertise, you can avoid costly errors, eliminate last-minute stress, and safely secure your place in the EU and Swiss markets.

Don’t wait until the deadlines are looming—contact us today to access flexible, end-to-end solutions for EUDAMED and Swissdamed management.

Even if you already have an EC REP, we serve as your trusted technical partner, expertly handling preparation, validation, and pload (XML) of your UDI-DI data, ensuring your submissions are accurate, timely, and fully compliant.